BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.8238
-0.0242 (-2.85%)
At close: Dec 5, 2025, 4:00 PM EST
0.8499
+0.0261 (3.17%)
After-hours: Dec 5, 2025, 7:49 PM EST
BioAtla Market Cap
BioAtla has a market cap or net worth of $48.43 million as of December 5, 2025. Its market cap has decreased by -33.21% in one year.
Market Cap
48.43M
Enterprise Value
46.29M
1-Year Change
-33.21%
Ranking
Category
Stock Price
$0.82
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $577.60M to $48.43M, a decrease of -91.61%. That is a compound annual growth rate of -39.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 48.43M | 41.19% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -69.81% |
| Dec 30, 2022 | 390.66M | -45.97% |
| Dec 31, 2021 | 723.09M | -36.84% |
| Dec 31, 2020 | 1.14B | 98.22% |
| Dec 16, 2020 | 577.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |